These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39074106)

  • 1. Availability of essential medicines during the COVID-19 pandemic: A qualitative study examining experiences and level of preparedness in Kenya.
    Onyango JO; Ogira D; Kokwaro G
    PLOS Glob Public Health; 2024; 4(7):e0002547. PubMed ID: 39074106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the COVID-19 Pandemic on Medical Product Procurement, Prices, and Supply Chain in Zimbabwe: Lessons for Supply Chain Resiliency.
    Yemeke TT; Umaru FA; Ferrand RA; Ozawa S
    Glob Health Sci Pract; 2023 Oct; 11(5):. PubMed ID: 37903588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Availability of essential, generic medicines before and during COVID-19 at selected public pharmaceutical supply agencies in Ethiopia: a comparative cross-sectional study.
    Melaku T; Mekonnen Z; Terefe Tucho G; Mecha M; Årdal C; Jahre M
    BMJ Open; 2024 Mar; 14(3):e077545. PubMed ID: 38443082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of COVID-19 on health financing in Kenya.
    Kairu A; Orangi S; Mbuthia B; Arwah B; Guleid F; Keru J; Vilcu I; Musuva A; Ravishankar N; Barasa E
    PLOS Glob Public Health; 2023; 3(10):e0001852. PubMed ID: 37889878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Policies for type 2 diabetes and non-communicable disease management during the COVID-19 pandemic in Kenya and Tanzania: a desk review and views of decision-makers.
    Mohamed SF; Kisia L; Mashiashi I; Mair F; Wisdom JP; Bunn C; Gray C; Kibe PM; Sanya RE; Karugu CH; Mtenga SM; Binyaruka P; Asiki G
    BMJ Open; 2024 Mar; 14(3):e073261. PubMed ID: 38531573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of access to childhood cancer medicines: a comparative, mixed-methods analysis of four Caribbean countries.
    Boateng R; Petricca K; Tang B; Parikh S; SinQuee-Brown C; Alexis C; Browne-Farmer C; Reece-Mills M; Salmon SM; Bodkyn C; Gupta S; Maguire B; Denburg AE
    Lancet Glob Health; 2021 Sep; 9(9):e1314-e1324. PubMed ID: 34416215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Affecting the Availability and Utilization of Essential Medicines in India: A Systematic Review.
    Wadhwa M; Trivedi P; Raval D; Saha S; Prajapati H; Gautam R; Jagadeesh KV; Rajshekhar K
    J Pharm Bioallied Sci; 2024 Apr; 16(Suppl 2):S1064-S1071. PubMed ID: 38882835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global Health System Resilience during Encounters with Stressors - Lessons Learnt from Cancer Services during the COVID-19 Pandemic.
    Yeoh K; Wu Y; Chakraborty S; Elhusseiny G; Gondhowiardjo S; Joseph N; Lee AWM; Loong HH; Msadabwe-Chikuni SC; Tan BF; Ospina AV; Roques T; Shum HM; Yeoh EK
    Clin Oncol (R Coll Radiol); 2023 Apr; 35(4):e289-e300. PubMed ID: 36764875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of Kenya's cancer policies to improve access to cancer testing and treatment in the country.
    Makau-Barasa LK; Greene S; Othieno-Abinya NA; Wheeler SB; Skinner A; Bennett AV
    Health Res Policy Syst; 2020 Jan; 18(1):2. PubMed ID: 31910868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tackling medicine shortages during and after the COVID-19 pandemic: Compilation of governmental policy measures and developments in 38 countries.
    Vogler S
    Health Policy; 2024 May; 143():105030. PubMed ID: 38484475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of COVID-19 on Pharmaceutical Shortages and Supply Disruptions for Non-Communicable Diseases Among Public Hospitals of South West, Oromia, Ethiopia.
    Jifar WW; Geneti GB; Dinssa SD
    J Multidiscip Healthc; 2022; 15():1933-1943. PubMed ID: 36072279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of government agencies and other actors in influencing access to medicines in three East African countries.
    Odoch WD; Dambisya Y; Peacocke E; Sandberg KI; Hembre BSH
    Health Policy Plan; 2021 Apr; 36(3):312-321. PubMed ID: 33569583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons learned from the experiences and perspectives of frontline healthcare workers on the COVID-19 response: a qualitative descriptive study.
    Orhierhor M; Pringle W; Halperin D; Parsons J; Halperin SA; Bettinger JA
    BMC Health Serv Res; 2023 Oct; 23(1):1074. PubMed ID: 37805603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients Access to Medicines - A Critical Review of the Healthcare System in Kenya.
    Toroitich AM; Dunford L; Armitage R; Tanna S
    Risk Manag Healthc Policy; 2022; 15():361-374. PubMed ID: 35256867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Devolution and its effects on health workforce and commodities management - early implementation experiences in Kilifi County, Kenya.
    Tsofa B; Goodman C; Gilson L; Molyneux S
    Int J Equity Health; 2017 Sep; 16(1):169. PubMed ID: 28911328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health system determinants of access to essential medicines for children with cancer in Ghana.
    Boateng R; Renner L; Petricca K; Gupta S; Denburg A
    BMJ Glob Health; 2020 Sep; 5(9):. PubMed ID: 32967979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procurement process and shortages of essential medicines in public health facilities: A qualitative study from Nepal.
    Adhikari B; Ranabhat K; Khanal P; Poudel M; Marahatta SB; Khanal S; Paudyal V; Shrestha S
    PLOS Glob Public Health; 2024; 4(5):e0003128. PubMed ID: 38696399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interface policies bridging outpatient and hospital sectors in Europe: can cross-sectorial collaboration in reimbursement and procurement improve access to affordable medicines?
    Vogler S; Salcher-Konrad M; Habimana K
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(8):867-878. PubMed ID: 37450611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scaling up antiretroviral therapy in Uganda: using supply chain management to appraise health systems strengthening.
    Windisch R; Waiswa P; Neuhann F; Scheibe F; de Savigny D
    Global Health; 2011 Aug; 7():25. PubMed ID: 21806826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspective: Lessons from COVID-19 of countries in the European region in light of findings from the health system response monitor.
    Tille F; Van Ginneken E; Winkelmann J; Hernandez-Quevedo C; Falkenbach M; Sagan A; Karanikolos M; Cylus J
    Front Public Health; 2022; 10():1058729. PubMed ID: 36684940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.